Internal Reference Number: FOI_8038
Date Request Received: 08/07/2024 00:00:00
Date Request Replied To: 26/07/2024 00:00:00
This response was sent via: By Email
Request Summary: Endometrial Cancer
Request Category: Researcher
| Question Number 1: I would greatly appreciate if you could answer the following questions. Does your trust provide SACT (systemic anti-cancer therapy) treatments for endometrial cancer? If not, which other trust do you refer endometrial cancer patients to for SACT treatments? | |
| Answer To Question 1: Yes | |
| Question Number 2: How many patients were treated for endometrial cancer (any stage) in the past three months with the following treatments: 鈥� Dostarlimab (Jemperli) 鈥� Dostarlimab (Jemperli) AND Chemotherapy 鈥� Hormone therapy (Progesterone or Letrozole) 鈥� Pembrolizumab (Keytruda) monotherapy 鈥� Lenvatinib + Pembrolizumab (Lenvima +Keytruda)鈥� 鈥� Platinum-based chemotherapy (monotherapy or combination with taxanes, anthracyclines, cyclophosphamide) 鈥� Any other SACT | |
| Answer To Question 2: Less than 5. | |
| Question Number 3: In the past three months, how many patients were treated for recurrent endometrial cancer after having previously received platinum-based chemotherapy? | |
| Answer To Question 3: 0 | |
| Question Number 4: In the past three months, how many patients were treated for endometrial cancer with the following as first line treatments: 鈥� Dostarlimab (Jemperli) AND Chemotherapy 鈥� Hormone therapy (Progesterone or Letrozole) 鈥� Platinum-based chemotherapy (monotherapy or combination with taxanes, anthracyclines, cyclophosphamide) 鈥� Any other SACT | |
| Answer To Question 4: Less than 5. | |
| Question Number 5: Does your trust participate in any clinical trials for the treatment of endometrial cancer? If so, can you please provide the name of each trial and the number of patients taking part. | |
| Answer To Question 5: Our Trust took part in one study in this area, National Study of Endometrial Cancer Genetics. The study ended in 2014 and had recruited 17 participants. | |
| To return to the list of all the FOI requests please click here |
Our staff at 91影视 District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
